Compare SBFM & FLGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SBFM | FLGC |
|---|---|---|
| Founded | 2006 | 2019 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.2M | 7.6M |
| IPO Year | N/A | 2021 |
| Metric | SBFM | FLGC |
|---|---|---|
| Price | $1.37 | $7.69 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $7.00 | N/A |
| AVG Volume (30 Days) | 55.6K | ★ 63.6K |
| Earning Date | 11-13-2025 | 11-05-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $37,323,742.00 | ★ $57,609,000.00 |
| Revenue This Year | $10.26 | N/A |
| Revenue Next Year | $32.63 | $0.13 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | 13.24 | ★ 24.71 |
| 52 Week Low | $1.16 | $5.86 |
| 52 Week High | $3.90 | $47.00 |
| Indicator | SBFM | FLGC |
|---|---|---|
| Relative Strength Index (RSI) | 44.63 | 40.78 |
| Support Level | $1.16 | $5.86 |
| Resistance Level | $1.40 | $7.55 |
| Average True Range (ATR) | 0.08 | 1.05 |
| MACD | 0.01 | 0.02 |
| Stochastic Oscillator | 53.13 | 25.27 |
Sunshine Biopharma Inc is a pharmaceutical company offering and researching life-saving medicines in a wide variety of therapeutic areas, including oncology and antivirals. Through its subsidiaries, the company has various generic prescription drugs on the market in Canada and is also involved in developing and selling OTC supplements. In addition, the company is conducting a proprietary drug development program, which is comprised of K1.1 mRNA targeted for liver cancer and SBFM-PL4, PLpro protease inhibitor for SARS Coronavirus infections.
Flora Growth Corp is a multi-national cannabis company that manufactures and distributes consumer packaged goods, cultivates and distributes medicinal cannabis, and distributes pharmaceutical products. Its reportable segments are: the commercial and wholesale segment (FGH and Cosechemos subsidiaries) and the house of brands segment (JustCBD, Vessel, and Kasa Wholefoods Company subsidiaries). Geographically, the company generates revenue from the United States, Germany, Australia, and the United Kingdom. It generates revenue as a distributor of pharmaceutical goods, and a manufacturer and reseller of a range of cannabis-based and complementary products.